A normal genetic variation modulates synaptic MMP‐9 protein levels and the severity of schizophrenia symptoms

Matrix metalloproteinase 9 (MMP‐9) has recently emerged as a molecule that contributes to pathological synaptic plasticity in schizophrenia, but explanation of the underlying mechanisms has been missing. In the present study, we performed a phenotype‐based genetic association study (PGAS) in > 1,...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:EMBO Mol Med
Hoofdauteurs: Lepeta, Katarzyna, Purzycka, Katarzyna J, Pachulska‐Wieczorek, Katarzyna, Mitjans, Marina, Begemann, Martin, Vafadari, Behnam, Bijata, Krystian, Adamiak, Ryszard W, Ehrenreich, Hannelore, Dziembowska, Magdalena, Kaczmarek, Leszek
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: John Wiley and Sons Inc. 2017
Onderwerpen:
Research Articles
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5538295/
https://ncbi.nlm.nih.gov/pubmed/28623238
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15252/emmm.201707723
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items